Finance

Lists
DHER34:BVMF
Danaher Corporation Bdr
39,36 R$
0,00%
(0,00) 1D
9 қаз., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DHER34...
Open
39,18 R$
High
39,36 R$
Low
39,18 R$
Mkt. cap
154,52 млрд
Avg. vol.
2,36 мың
Volume
404,00
52-wk high
45,87 R$
52-wk low
27,94 R$
Shares outstanding
702,99 млн
No. of employees
59 мың
Open
39,18 R$
High
39,36 R$
Low
39,18 R$
Mkt. cap
154,52 млрд
Avg. vol.
2,36 мың
Volume
404,00
52-wk high
45,87 R$
52-wk low
27,94 R$
Shares outstanding
702,99 млн
No. of employees
59 мың
News stories
From web sources and news partners
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr
CEORainer M. Blair
Employees59 мың
Founded1969
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
6,05 млрд
6,84 млрд
5,95 млрд
6,26 млрд
Cost of goods sold
2,53 млрд
2,86 млрд
2,36 млрд
2,61 млрд
Cost of revenue
2,53 млрд
2,86 млрд
2,36 млрд
2,61 млрд
Research and development expenses
378,00 млн
438,00 млн
387,00 млн
412,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 млрд
2,03 млрд
1,84 млрд
2,01 млрд
Operating expense
2,27 млрд
2,46 млрд
2,23 млрд
2,42 млрд
Total operating expenses
4,80 млрд
5,32 млрд
4,59 млрд
5,03 млрд
Operating income
1,26 млрд
1,52 млрд
1,36 млрд
1,24 млрд
Other non operating income
-
-87,00 млн
-
-
EBT including unusual items
1,08 млрд
1,37 млрд
1,24 млрд
1,08 млрд
EBT excluding unusual items
1,19 млрд
1,39 млрд
1,33 млрд
1,19 млрд
Income tax expense
168,00 млн
190,00 млн
206,00 млн
208,00 млн
Effective tax rate
15,61%
13,84%
16,68%
19,29%
Other operating expenses
-
-
-
-
Net income
908,00 млн
1,20 млрд
1,03 млрд
870,00 млн
Net profit margin
15,00%
17,51%
17,29%
13,89%
Earnings per share
1,89
2,23
2,06
1,94
Interest and investment income
3,00 млн
13,00 млн
27,00 млн
61,00 млн
Interest expense
-67,00 млн
-55,00 млн
-63,00 млн
-107,00 млн
Net interest expenses
-64,00 млн
-42,00 млн
-36,00 млн
-46,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,88 млрд
2,14 млрд
1,99 млрд
1,90 млрд
Gain or loss from assets sale
-9,00 млн
9,00 млн
-
-
AI content may include mistakes. Learn more
Google қолданбалары